Rad51 promoter-targeted gene therapy is effective for in vivo visualization and treatment of cancer.
Hine CM; Seluanov A; Gorbunova V; Molecular Therapy: The Journal Of The American Society Of Gene Therapy, 2012, vol. 20, issue 2, p 347, ISSN 15250024. ISBN 15250024.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef